Cite
HARVARD Citation
Nezamololama, N. et al. (2020). Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis. Expert opinion on investigational drugs. pp. 911-917. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nezamololama, N. et al. (2020). Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis. Expert opinion on investigational drugs. pp. 911-917. [Online].